高级检索
当前位置: 首页 > 详情页

Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion: A prospective cohort study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Hepat Surg Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Translat Med Ctr, Wuhan 430030, Hubei, Peoples R China
出处:
ISSN:

关键词: Microvascular invasion Hepatocellular carcinoma Anatomic resection Surgical margin Recurrence Surgery

摘要:
BACKGROUND The long-term effect of anatomic resection (AR) is better than that of nonanatomic resection (NAR). At present, there is no study on microvascular invasion (MVI) and liver resection types. AIM To explore whether AR improves long-term survival in patients with hepatocellular carcinoma (HCC) by removing the peritumoral MVI. METHODS A total of 217 patients diagnosed with HCC were enrolled in the study. The surgical margin was routinely measured. According to the stratification of different tumor diameters, patients were divided into the following groups: <= 2 cm group, 2-5 cm group, and > 5 cm group. RESULTS In the 2-5 cm diameter group, the overall survival (OS) of MVI positive patients was significantly better than that of MVI negative patients (P = 0.031). For the MVI positive patients, there was a statistically significant difference between AR and NAR (P = 0.027). AR leads to a wider surgical margin than NAR (2.0 +/- 2.3 cm vs 0.7 +/- 0.5 cm, P < 0.001). In the groups with tumor diameters < 2 cm, both AR and NAR can obtain a wide surgical margin, and the surgical margins of AR are wider than that of NAR (3.5 +/- 5.8 cm vs 1.6 +/- 0.5 cm, P = 0.048). In the groups with tumor diameters > 5 cm, both AR and NAR fail to obtain wide surgical margin (0.6 +/- 1.0 cm vs 0.7 +/- 0.4 cm, P = 0.491). CONCLUSION For patients with a tumor diameter of 2-5 cm, AR can achieve the removal of peritumoral MVI by obtaining a wide incision margin, reduce postoperative recurrence, and improve prognosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 4 区 胃肠肝病学 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q3 GASTROENTEROLOGY & HEPATOLOGY Q3 ONCOLOGY
最新[2023]版:
Q3 GASTROENTEROLOGY & HEPATOLOGY Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Hepat Surg Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:408 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)